Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Renal Cell 4Neoplasms 2Kidney Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thoracic Neoplasms 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Pleural Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Ovarian Neoplasms 1Neoplasms by Site 1Lung Neoplasms 1Lung Diseases 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Gastro Intestinal Stromal Tumor 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma, Bronchogenic 1

Interventions

selpercatinib 2pralsetinib 2sotorasib 1pembrolizumab 1patritumab 1osimertinib 1durvalumab 1cobimetinib 1alectinib 1Tyrosine Kinase Inhibitors 1Radiosurgery 1Pemetrexed 1Paclitaxel 1Gemcitabine 1Erlotinib Hydrochloride 1Dasatinib 1Cisplatin 1Carboplatin 1Afatinib 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Respiratory Tract Diseases × Tyrosine Kinase Inhibitors × Clear all
NCT01999985 2020-11-27

Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
25 enrolled 10 charts
Thoracic

Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Pleural Diseases, Pleural Effusion, Pleural Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡